Anxiety disorders affect 19.1 percent of US adults — 42.5 million people — making them the most common mental health condition in the country. Yet only 1 in 4 people with an anxiety disorder receives any treatment. This complete guide covers all 6 major types from GAD to panic disorder and social anxiety, the biological causes including amygdala hyperactivity and HPA axis dysregulation, and the full treatment spectrum from CBT and SSRIs to Pregabalin and the correct role of b

Pregabalin and Gabapentin are both gabapentinoids with the same mechanism — but Pregabalin has 90 percent linear bioavailability vs Gabapentin's unpredictable 33 to 60 percent. Pregabalin has Phase III RCT evidence for GAD and European regulatory approval. Gabapentin has neither. This complete comparison covers the pharmacological differences, the anxiety evidence base, side effects, and a clear indication guide for which to choose.

Generalized Anxiety Disorder affects 6.8 million Americans — yet most live with it for years before receiving the right diagnosis and treatment. This complete guide covers how GAD differs from normal anxiety, the GAD-7 diagnostic scale, all treatment options including Pregabalin (FDA-approved for GAD), SSRIs, CBT, and the lifestyle changes with the strongest evidence.